US vaccine mandates and Supreme Court litigation
On 13 January 2022, the United States Supreme Court blocked enforcement of a broad federal workplace vaccination-or-testing requirement but permitted a different rule covering staff at many Medicare- and Medicaid-funded healthcare facilities. The paired decisions emerged after the Biden administration had tried to reduce the transmission and severity of COVID-19 through federal workplace regulation in 2021.
Read the full background
Two mandate cases, opposite emergency rulings
On 13 January 2022, the United States Supreme Court blocked enforcement of a broad federal workplace vaccination-or-testing requirement but permitted a different rule covering staff at many Medicare- and Medicaid-funded healthcare facilities. The paired decisions emerged after the Biden administration had tried to reduce the transmission and severity of COVID-19 through federal workplace regulation in 2021. The contrast is central: the justices did not issue a single general holding that vaccine requirements were either universally lawful or universally unconstitutional. They examined two statutory delegations involving different regulated employers and different agency responsibilities.
In National Federation of Independent Business v. OSHA, the Occupational Safety and Health Administration had required large employers with at least 100 workers to implement vaccination or regular testing obligations, subject to specified exceptions. On 13 January 2022, a majority of the Supreme Court stayed the emergency temporary standard. The court reasoned that occupational-safety authority did not clearly authorise such an expansive nationwide public-health intervention. The decision limited OSHA's chosen approach to the COVID-19 pandemic while leaving unresolved other workplace and state-level public-health powers.
The same day, Biden v. Missouri produced a different result. The justices allowed the Centers for Medicare and Medicaid Services to proceed with vaccination requirements for staff in participating healthcare facilities. The court held that protecting patients from infection was within the agency's statutory responsibilities when attaching conditions to federal healthcare programmes. The vote was 5–4, and the four dissenting justices challenged the agency's basis for imposing the requirement. The outcome made a federal workplace mandate invalid in one major regulatory setting while permitting a healthcare-specific measure in another.
Both cases had been argued on 7 January 2022, just six days before the opinions. The compressed calendar mattered to hospitals, nursing facilities and employers preparing compliance arrangements. Businesses subject to the OSHA standard gained relief from a federal obligation that could have affected millions of employees; healthcare providers remained exposed to the separate CMS conditions. The immediate results were legal changes, not direct measurements of infections prevented, lives saved or vaccine uptake attributable to either judgment. Those would require epidemiological evidence linked to the affected populations.
The decisions demonstrate the Supreme Court's conservative transformation in a concrete institutional setting, though the vote divisions differed across the paired rulings. The cases also intersected vaccine hesitancy: public conflict about mandates included resistance based on personal liberty, religion, employment conditions and confidence in vaccine policy. A legal defeat for OSHA was not proof that vaccination lacked medical benefit, just as a legal victory for CMS was not proof that all federal rules would survive scrutiny. Public-health efficacy, statutory competence and proportionality are separate questions.
In the months after January 2022, employers and healthcare facilities made decisions under different federal and state legal frameworks. The decisions changed who could require compliance and on what authority; they did not end the pandemic or remove all vaccine requirements. A comparison with Austria's vaccination mandate highlights the institutional difference between a national legislative requirement and an American executive-agency rule. The lasting issue from 13 January 2022 is the boundary drawn around federal agency power during an acute public-health emergency, with divergent outcomes for ordinary large workplaces and federally funded care facilities.
Evidence
Review status of the facts behind this driver.
By the Factrail desk · Method: how we source and score · Last reviewed